Kidney disease: Wherefore, whence, and whereto?

被引：7

作者：

Eknoyan, Garabed ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

来源：

KIDNEY INTERNATIONAL | 2007年 / 71卷 / 06期

关键词：

D O I：

10.1038/sj.ki.5002171

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：473 / 475

页数：3

共 13 条

[1] ALTMAN L, 2007, NY TIMES 0105, pA8
[2] Introduction - First words
Culotta, E
Hanson, B
[J]. SCIENCE, 2004, 303 (5662) : 1315 - 1315
[3] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
Eknoyan, G
Levin, NW
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266
[4] The dialysis outcomes quality initiative: History, impact, and prospects
Eknoyan, G
Levin, NW
Steinberg, EP
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : S69 - S75
[5] Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996
[6] Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Levey, AS
Eckardt, KU
Tsukamoto, Y
Levin, A
Coresh, J
Rossert, J
de Zeeuw, D
Hostetter, TH
Lameire, N
Eknoyan, G
[J]. KIDNEY INTERNATIONAL, 2005, 67 (06) : 2089 - 2100
[7] Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the National Kidney Disease Education Program
Myers, GL
Miller, WG
Coresh, J
Fleming, J
Greenberg, N
Greene, T
Hostetter, T
Levey, AS
Panteghini, M
Welch, M
Eckfeldt, JH
[J]. CLINICAL CHEMISTRY, 2006, 52 (01) : 5 - 18
[8] Obrador G T, 1998, J Am Soc Nephrol, V9, pS44
[9] Prevention of progression and remission/regression strategies for chronic renal diseases: Can we do better now than five years ago?
Perico, N
Codreanu, I
Schieppati, A
Remuzzi, G
[J]. KIDNEY INTERNATIONAL, 2005, 68 : S21 - S24
[10] International Society of Nephrology: A forty year history 1960-2000
Robinson, RR
Richet, G
[J]. KIDNEY INTERNATIONAL, 2001, 59 : S1 - S100

← 1 2 →